Starter PacksStarter Packs
Support

Steven Merlin

Stage IV survivor of pancreatic cancer diagnosed in June 2012. Underwent Whipple procedure with portal vein resection followed by aggressive chemotherapy and the first US patient enrolled in the PARP-1 inhibitor trial RucaPANC at Penn Medicine.

View in Bluesky

Subscribe to get the latest
Starter Packs Starter Packs updates.

0

Starter Packs to explore and growing...

Explore

Bluesky Starter Packs

Bluesky Profiles

Leaderboard

Resources

Pricing

Popular Searches

Brought to you by

© 2024 - 2025 — Starter Packs by

Ryan Hefner
Stripe Climate Badge

1% of purchases is contributed to removing CO₂ from the atmosphere. Learn more